Furthermore, the expression pattern of ADAM17 in relation to GBM progression was investigated by analyzing RNA sequencing data obtained from the CGGA dataset, which were grouped according to the WHO glioma grades. The gene discussed is ADAM17; the disease is central nervous system cancer.